Harwood Feffer LLP Announces Investigation Of Eloqua, Inc.
NEW YORK, Dec. 20, 2012 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Eloqua, Inc. ("Eloqua" or the "Company") (NASDAQ: ELOQ) concerning the proposed acquisition the Company by Oracle Corp. ("Oracle") in a transaction valued at approximately $810 million.
On December 20, 2012, Eloqua announced that it had entered into a definitive agreement pursuant to which the Company will be acquired by Oracle. Under the terms of the agreement, Eloqua shareholders will receive $23.50 for each share owned.
Our investigation concerns whether the Eloqua board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders.
If you own Eloqua shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:Benjamin Sachs-Michaels, Esq. Robert I. Harwood, Esq.Harwood Feffer LLP488 Madison Avenue New York, New York 10022Phone Numbers: (877) 935-7400(212)935-7400Email: email@example.comWebsite: http://www.hfesq.com Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( http://www.hfesq.com) for more information about the firm. Attorney Advertising © 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. SOURCE Harwood Feffer LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts